Xhale

About:

Xhale features a SMART medication adherence monitoring technology and on a propofol monitor.

Top Investors: National Institutes of Health

Description:

Xhale features a SMART medication adherence monitoring technology and on a propofol monitor. In 2008, the company began the development of a third product line, the HyGreen hand hygiene monitoring, and the recording system. By 2010, Xhale had successfully commercialized HyGreen, and the product was spun out as a stand-alone company with a separate management team. It was founded in 2005 and headquartered in Gainesville, Florida.

Total Funding Amount:

$22.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Gainesville, Florida, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)xhale.com

Founders:

Donn Dennis, Richard J. Melker, Richard R. Allen

Number of Employees:

11-50

Last Funding Date:

2014-07-22

IPO Status:

Private

Industries: